Judith Dotson - 19 May 2022 Form 4 Insider Report for Booz Allen Hamilton Holding Corp (BAH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 May 2022, 16:36:39 UTC
Prior SEC filing
19 May 2022
Next SEC filing
03 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Lubna Malik, as Attorney-in-Fact for Judith Dotson

Key filing fact

Judith Dotson filed Form 4 for Booz Allen Hamilton Holding Corp (BAH) on 23 May 2022.

Key facts

  • This page summarizes Judith Dotson's Form 4 filing for Booz Allen Hamilton Holding Corp (BAH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 23 May 2022, 16:36.

Change

  • Previous filing in this sequence was filed on 19 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BAH transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+5,320
Change %
+9.9%
Price
$0.000000
Shares after
59,038
Date
19 May 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of restricted stock units under the Issuer's Third Amended and Restated Equity Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A common stock upon vesting. One-third of these restricted stock units are scheduled to vest on each of March 31, 2023, 2024 and 2025, subject to the Reporting Person's continued employment.

Footnote F2

Includes restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .